Natural resistance to HIV infection: The Vif-APOBEC interaction

Comptes Rendus - Biologies

Volumn 329, Issue 11, 2006, Pages 871-875

  Malim, Michael H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

APOBEC; HIV; Hypermutation; Vif; Viral resistance

Indexed keywords

ADENOSINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE; COMPLEMENTARY DNA; CYTIDINE; CYTIDINE DEAMINASE; GUANOSINE; POLYNUCLEOTIDE; UNCLASSIFIED DRUG; URIDINE; VIF PROTEIN;

CELL ORGANELLE; DNA; HUMAN IMMUNODEFICIENCY VIRUS; VIRAL DISEASE;

DEAMINATION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION; SHORT SURVEY; VIRION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS RESISTANCE; WILD TYPE;

ANIMALS; CYTIDINE DEAMINASE; DEAMINATION; DNA, COMPLEMENTARY; GENE PRODUCTS, VIF; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; MUTATION; PHENOTYPE; VIRUS REPLICATION;

EID: 33750997315     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2006.01.012     Document Type: Short Survey

References (31)

1. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
2. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
3. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 113 (2003) 803-809
4. Lecossier D., Bouchonnet F., Clavel F., and Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300 (2003) 1112
5. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
6. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 (2003) 94-98
7. Suspene R., Sommer P., Henry M., Ferris S., Guetard D., Pochet S., Chester A., Navaratnam N., Wain-Hobson S., and Vartanian J.P. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32 (2004) 2421-2429
8. Yu Q., Konig R., Pillai S., Chiles K., Kearney M., Palmer S., Richman D., Coffin J.M., and Landau N.R. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11 (2004) 435-442
9. Simon J.H., and Malim M.H. The human immunodeficiency virus type-1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70 (1996) 5297-5305
10. Harris R.S., Sheehy A.M., Craig H.M., Malim M.H., and Neuberger M.S. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat. Immunol. 4 (2003) 641-643
11. Newman E.N., Holmes R.K., Craig H.M., Klein K.C., Lingappa J.R., malim M.H., and Sheehy A.M. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15 (2005) 166-170
12. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., and Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435 (2005) 108-114
13. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., and Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 (2003) 1056-1060
14. Sheehy A.M., Gaddis N.C., and Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9 (2003) 1404-1407
15. Stopak K., de Noronha C., Yonemoto W., and Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12 (2003) 591-601
16. Mehle A., Goncalves J., Santa-Marta M., McPike M., and Gabuzda D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18 (2004) 2861-2866
17. Yu Y., Xiao Z., Ehrlich E.S., Yu X., and Yu X.F. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18 (2004) 2867-2872
18. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., and Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114 (2003) 21-31
19. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., and Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14 (2004) 1392-1396
20. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., and Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78 (2004) 6073-6076
21. Wiegand H.L., Doehle B.P., Bogerd H.P., and Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23 (2004) 2451-2458
22. Liddament M.T., Brown W.L., Schumacher A.J., and Harris R.S. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14 (2004) 1385-1391
23. Janini M., Rogers M., Birx D.R., and McCutchan F.E. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J. Virol. 75 (2001) 7973-7986
24. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., and Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337 (2004) 585-596
25. Vartanian J.P., Meyerhans A., Asjo B., and Wain-Hobson S. Selection, recombination, and G → A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65 (1991) 1779-1788
26. Vartanian J.P., Meyerhans A., Sala M., and Wain-Hobson S. G → A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc. Natl Acad. Sci. USA 91 (1994) 3092-3096
27. Kieffer T.L., Kwon P., Nettles R.E., Han Y., Ray S.C., and Siliciano R.F. G → A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J. Virol. 79 (2005) 1975-1980
28. Morley M., Molony C.M., weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., and Cheung V.G. Genetic analysis of genome-wide variation in human gene expression. Nature 430 (2004) 743-747
29. An P., Bleiber G., Duggal P., Nelson G., May M., Mangeat B., Alobwede I., Trono D., Vlahov D., Donfield S., Goedert J.J., Phair J., Buchbinder S., O'Brien S.J., Telenti A., and Winkler C.A. APOBEC3G genetic variants and their influence on the progression to AIDS. J. Virol. 78 (2004) 11070-11076
30. Do H., Vasilescu A., Diop G., Hirtzig T., Heath S.C., Coulonges C., Rappaport J., Therwath A., Lathrop M., Matsuda F., and Zagury J.F. Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. J. Infect. Dis. 191 (2005) 159-163
31. Jin X., Brooks A., Chen H., Bennett R., Reichman R., and Smith H. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J. Virol. 79 (2005) 11513-11516